Lifevantage Corporation (NASDAQ:LFVN)

Wednesday, May 7, 2025 | Web News
LifeVantage Corporation (NASDAQ:LFVN) ($11.97; $150.2M market cap) announced Q3 2025 results: Q3 sales of...
Tuesday, March 4, 2025 | Web News
Lifevantage Corporation (NASDAQ:LFVN) ($16.82; $216.5 M market cap) announced the launch of the Evolve Compensation plan into the Philippines,...
Thursday, February 6, 2025 | Web News
Lifevantage Corporation (NASDAQ:LFVN) ($22.74; $284.8 M market cap) (currently marked down ~20% pre market) announced Q2...
See All Research...
Friday, July 26, 2024, 9:17 AM
GLP-1 Natural Weight Loss Therapy Gives LFVN A Life Line
See All Articles and Reports...
Sunday, May 11, 2025, 4:29 PM
Real Signals, Not Just Hype: A Deep-Dive Open Forum Event [GeoWire Weekly No. 186] | TGEN ACFN PSIX CURI FSI FALC MOJO VMD FTK MUEL BURCA CSBR BLM.V
Sunday, March 23, 2025, 12:26 PM
Turnarounds, Breakouts, And Bullish Setups From Last Week [GeoWire Weekly No. 179]
Sunday, March 9, 2025, 2:23 PM
Preliminary Comments on Launch of New Buy on Pullback Model Portfolio #13; Virtual Conference Replays Available [GeoWire Weekly No. 177]
See All GeoWire Weekly...

LifeVantage maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level.

Web site: http:// www.LifeVantage.com

Last updated June 6, 2008


Market Data powered by QuoteMedia. Terms of Use